Subscribe to Cardiovascular
View Sample

FREE Email Newsletter

US Demand for Implantable Medical Devices to Reach $52 Billion in 2015

March 22, 2012 7:35 am | News | Comments

US demand for implantable medical devices is forecast to increase 7.7 percent annually to $52 billion in 2015, benefiting from technological advances and the development of next generation devices that should increase patient and provider confidence in implant products.

Prepare for Tough Times in the US, Heart Surgery Device Suppliers are Told

March 22, 2012 7:10 am | News | Comments

NEW YORK (GBI Research) - Cardiovascular surgery device suppliers must prepare for tough times ahead in America, according to a new report by business intelligence expert GBI Research. The new report states that instances of cardiac surgery will fall in the US, which represents the largest national market for this treatment...

Expanded Capabilities in Weaving Medical Textiles for Vascular Grafts

March 15, 2012 5:51 am | Product Releases | Comments

Biomedical Structures LLC (BMS), a developer of biomedical textiles for medical devices and other advanced clinical applications, today announced new capabilities for the high-precision...


Interventional Cardiology Device Markets in Pakistan, Saudi Arabia, South Africa and Turkey to Grow to $461 Million by 2016

March 13, 2012 12:05 pm | News | Comments

TORONTO--(BUSINESS WIRE)--According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the interventional cardiology (IC) market in Pakistan, Saudi Arabia, South Africa and Turkey will reach a value of more than $460 million by 2016.

Hospira Receives FDA Clearance for Symbiq 3.13 Infusion Pump

March 13, 2012 11:48 am | News | Comments

LAKE FOREST, Ill., -- Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, announced today that the company has received regulatory clearance from the U.S. Food and Drug Administration (FDA) for the Symbiq™ 3.13 infusion device, the enhanced version...

Asahi Kasei Announces Agreement to Acquire ZOLL Medical

March 12, 2012 5:12 am | News | Comments

Asahi Kasei, through a U.S. subsidiary, will make a cash tender offer to purchase all of the outstanding shares of ZOLL common stock for $93 per share. The purchase price represents a premium of 29.6% over ZOLL's volume weighted average closing stock price over the 30 trading day period...

Avinger Enrolls First U.S. PAD Patient in CONNECT II Global Clinical Trial

March 8, 2012 5:43 am | News | Comments

Avinger, Inc., a medical device manufacturer of innovative, multi-functional catheters for treating patients with Peripheral Artery Disease (PAD), announces the enrollment of the first U.S. patient in the CONNECT II global clinical trial. Dr. Ian Cawich of Arkansas Heart Hospital...

German Left Atrial Appendage Device Market to Challenge Novel Anticoagulants

March 8, 2012 5:39 am | News | Comments

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, procedures for Left Atrial Appendage (LAA) devices, intended to minimize stroke risk in patients with atrial fibrillation, have grown by over 200 percent in Germany since 2010.


Medtronic Receives CE Mark for Pacemaker Lead That Will Expand Patient Access to MRI Technology

March 6, 2012 4:54 am | News | Comments

Medtronic, Inc. today announced the receipt of CE Mark (Conformité Européenne) and launch of the CapSure Sense MRI™ SureScan® pacing leads, which are approved for use during Magnetic Resonance Imaging (MRI). Medtronic introduced the first MR-Conditional pacemaker system in the world in 2008 and in the U.S. in 2011.

Covidien Revascularization Device Receives FDA Clearance

March 6, 2012 4:52 am | News | Comments

Covidien, a leading global provider of healthcare products, today announced that the Solitaireâ„¢ FR revascularization device has been cleared by the U.S. Food and Drug Administration. The Solitaire FR device is intended to restore blood flow to the brain in patients suffering acute ischemic stroke by mechanically removing blood clots from blocked vessels.

Houston Medical Robotics, Inc. Receives FDA 510(k) Clearance for Euclid Tier 1 Mini Access System

March 6, 2012 4:48 am | News | Comments

Houston Medical Robotics, Inc. announces that it has received U.S. Food and Drug Administration 510(k) clearance to market the Euclidâ„¢ Tier 1 Mini Access System. The Euclidâ„¢ Tier 1 Mini Access System is a portable, hand-held device that integrates commercially available...

Medical Components, Inc. Awarded Agreement for Three Venous Access Catheter Categories with Novation LLC

February 10, 2012 10:53 am | News | Comments

HARLEYSVILLE, Pa.--(BUSINESS WIRE)--Medical Components, Inc. (aka Medcomp, Inc.) has been awarded a 36-month agreement with Novation, the leading health care supply contracting company for the members of VHA Inc., UHC, and Provista LLC, effective April 1, 2012.

Medtronic Stent Resulted in 90% Freedom from Reinterventions in Narrowed Leg Arteries at 12 Months in International Study

February 9, 2012 5:09 am | News | Comments

MINNEAPOLIS--(BUSINESS WIRE)--Consistent with its commitment to developing better treatments for peripheral arterial disease (PAD), Medtronic Inc. today announced the one-year results of an international study of the Complete SE (self-expanding) vascular stent for the treatment of atherosclerosis...


Sensable Customers Showcase Touch-Enabled Surgical, Medical Simulation and Robotics Innovations at MMVR Conference

February 8, 2012 5:21 am | News | Comments

WILMINGTON, Mass.--(BUSINESS WIRE)--Sensable's customers will feature prominently at the Medicine Meets Virtual Reality (MMVR) Conference in Newport Beach, California beginning tomorrow, where they will showcase innovative haptically-enabled surgical, medical simulation...

Robotic-Assisted PCI Procedures Using Corpath 200 System Will Be Discussed During CRT2012 Conference

February 7, 2012 5:08 am | News | Comments

NATICK, Mass. – Corindus Vascular Robotics, a leading developer of precision vascular robotics, today announced that Giora Weisz, M.D., Director of Clinical Cardiovascular Research at the Center for Interventional Vascular Therapy at NewYork-Presbyterian Hospital/Columbia University Medical Center...

Global Market for Catheters to Reach $32.1 Billion in 2016

February 6, 2012 5:54 am | News | Comments

Wellesley, Mass. – According to a new technical market research report, GLOBAL MARKETS FOR CATHETERS (HLC019E) from BCC Research, the global market for catheters reached nearly $21.2 billion in 2011 and is expected to increase...

Ostial Solutions, LLC Announces Successful Exit in Sale to Merit Medical Systems, Inc.

February 3, 2012 5:54 am | News | Comments

KALAMAZOO, Mich.--(BUSINESS WIRE)--Ostial Solutions, LLC, a privately-held company (the “Company”), today announced that it has sold substantially all of its assets to Merit Medical Systems, Inc. Terms of the transaction were not disclosed. Based in Kalamazoo, Michigan...

London meeting to provide unique insight into future of cardiovascular medicine

February 3, 2012 4:52 am | News | Comments

For cardiovascular scientists around the world London 2012 not only signifies the Olympics but also another major international event – the second Frontiers in Cardiovascular Biology (FCVB) meeting. FCVB 2012 will show case the best and latest science from the cardiovascular arena...

Strongest Growth in US Peripheral Vascular Market to Come in Lower Extremity Indications

February 2, 2012 5:30 am | News | Comments

TORONTO--(BUSINESS WIRE)--According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, strong growth in the United States peripheral vascular (PV) market will come in lower-extremity indications, particularly through the...

Medtronic Announces First Patient Enrollment in Clinical Trial Assessing Guideline-Based Heart Failure Management in Primary Care Setting

February 2, 2012 5:12 am | News | Comments

MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. today announced the initiation and first patient enrollment in a clinical study that will evaluate gaps in the implementation of evidence-based treatment guidelines among chronic heart failure patients post-hospital discharge.

Valley Presbyterian Hospital Site for First Use of New Heart Device in U.S. since FDA Approval

February 1, 2012 5:51 am | News | Comments

VAN NUYS, Calif.--(BUSINESS WIRE)--Valley Presbyterian Hospital (VPH) was the site for the first implantation in the U.S. of a new heart device since the Food and Drug Administration (FDA) approved the DF4 High-Voltage Connector System by Medtronic earlier this month...

Sorin Group Launches a New Complete Portfolio of Pacing, Defibrillation and Left Ventricular Leads

February 1, 2012 5:48 am | News | Comments

MILAN--(BUSINESS WIRE)--Sorin Group, a global medical company and a leader in the treatment of cardiovascular diseases, announced CE Mark approval and commercial launch for a comprehensive new range of pacing, defibrillation and left ventricular leads. Designed for safety...

DSM ComfortCoat hydrophilic coating enhances the capabilities of EPflex medical guidewires

February 1, 2012 5:31 am | News | Comments

DSM, a global leader in biomedical materials sciences, today announced a successful collaboration with medical manufacturer EPflex to launch a new set of guidewires with ComfortCoat® hydrophilic coating, a proprietary DSM technology. EPflex will manufacture...

Cook Medical Launches Zenith Low Profile Endovascular Graft in Canada

February 1, 2012 5:28 am | News | Comments

Stouffville, Ontario-Following Health Canada approval, the Zenith Low Profile AAA Endovascular Graft (Zenith AAA LP) from Cook Medical is now approved and will be launched to physicians in Canada. With a low-profile delivery system diameter of 18 Fr and simplified deployment...

Covidien Revascularization Device Approved for Interventional Management of Stroke Trial

January 31, 2012 6:01 am | News | Comments

MANSFIELD, Mass.--(BUSINESS WIRE)--Covidien, a leading global provider of healthcare products, today announced that the Solitaireâ„¢ FR Revascularization Device has been approved for investigational use in the Interventional Management of Stroke (IMS III) trial. The Solitaire FR...

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.